Engraftment occurred faster with FA-AML1 cells than with Kasumi-1 cells, which may reflect the relative aggressiveness of FA-AML1, which is a relapsed FA-AML, compared to the primary Kasumi-1 AML. The gene discussed is RUNX1; the disease is acute myeloid leukemia.